Manyun Dai
Chengdu, 610041, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Corrigendum to "Gut-vascular barrier mediated Tripterygium wilfordii-induced liver injury: the synergism between triptolide and celastrol via intestinal FXR-ET-1 pathway" [J. Ethnopharmacol. 349 (2025) 119900].
Journal: Journal of ethnopharmacology
Published: July 14, 2026
Gut-vascular barrier mediated Tripterygium wilfordii-induced liver injury: the synergism between triptolide and celastrol via intestinal FXR-ET-1 pathway.
Journal: Journal of ethnopharmacology
Published: February 28, 2025
Triptophenolide aggravates triptolide-induced liver injury through disrupting the biological function of intestine.
Journal: Toxicology and applied pharmacology
Published: December 24, 2024
Aspirin Caused Intestinal Damage through FXR and ET-1 Signaling Pathways.
Journal: International journal of molecular sciences
Published: February 23, 2024
Metabolomics Reveals Gut Microbiota Contribute to PPARα Deficiency-Induced Alcoholic Liver Injury.
Journal: Journal of proteome research
Published: May 26, 2023
Tripterygium wilfordii protects against an animal model of autoimmune hepatitis.
Journal: Journal of ethnopharmacology
Published: December 29, 2022
Celastrol as an intestinal FXR inhibitor triggers tripolide-induced intestinal bleeding: Underlying mechanism of gastrointestinal injury induced by Tripterygium wilfordii.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: December 22, 2022
Comparative Metabolomic Profiling of the Metabolic Differences of Δ9-Tetrahydrocannabinol and Cannabidiol.
Journal: Molecules (Basel, Switzerland)
Published: September 14, 2022
Metabolomics reveals the role of PPARα in Tripterygium Wilfordii-induced liver injury.
Journal: Journal of ethnopharmacology
Published: November 23, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026